Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients
NCT ID: NCT01285895
Last Updated: 2015-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2009-09-30
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific objectives : Evaluate the specific needs dependent on seniority transplantation : 3 to 6 months, 6 months to 2 years, more than 2 years after transplantation
Secondary objectives :
* Assess the state of health
* Assess the knowledge
* Assess gestural know-how
* Assess the cognitive know-how
* Assess the behaviour adopted in reality by the patient
* Assess motivation psychosocial factors of :
* self-efficacy and inefficiency
* representation of obstacles, disadvantages of treatment
* sense of control over their health
* feeling of being supported by health professionals, by his close
* representation of his responsibility to take care of his health, to follow his treatment, to be active about his treatment
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
NCT03357913
Evaluation of the Lung Clearance Index
NCT02342951
Development a Core Set for Adults With Cystic Fibrosis Based on the ICF
NCT06128499
Lung Transplant READY CF 2: A Multi-site RCT
NCT06030206
Improving Therapeutic Adherence With a Co-constructed Program Involving Both Patients and Health Care Professionals
NCT03226795
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patient in intensive care
* Palliative patient
* Patient aged under 18 years old
* Patient refusal
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valérie DAVID, Doctor
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Romain GUILLEMAIN, Profesor
Role: STUDY_CHAIR
Hôpital Européen Georges-Pompidou
Jean-François MORNEX, Profesor
Role: STUDY_CHAIR
Hospices Civils de Lyon
Marc STERN, Profesor
Role: STUDY_CHAIR
Hôpital Foch
Martine REYNAUD-GAUBERT, Profesor
Role: STUDY_CHAIR
CHU de Marseille
Marlène MURRIS-ESPIN, Doctor
Role: STUDY_CHAIR
University Hospital, Toulouse
Romain KESSLER, Profesor
Role: STUDY_CHAIR
CHU de Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROG/10/90
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.